Literature DB >> 4136585

Changes in immunospecificity and biologic activity of bovine insulin due to subsequent removal of the amino acids B1, B2, and B3.

L Kerp, S Steinhilber, H Kasemir, J Han, H R Henrichs, R Geiger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4136585     DOI: 10.2337/diab.23.8.651

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  5 in total

1.  Alteration in the immunochemical dominance of determinants following the chemical modification of ox insulins: implications for the structure of the ox insulin monomer in solution.

Authors:  P J Hollins; M M Nathan
Journal:  Clin Exp Immunol       Date:  1979-10       Impact factor: 4.330

2.  Additional disulfide bonds in insulin: Prediction, recombinant expression, receptor binding affinity, and stability.

Authors:  Tine N Vinther; Ingrid Pettersson; Kasper Huus; Morten Schlein; Dorte B Steensgaard; Anders Sørensen; Knud J Jensen; Thomas Kjeldsen; František Hubalek
Journal:  Protein Sci       Date:  2015-03-16       Impact factor: 6.725

3.  Immunological properties and biological effectiveness of insulin analogues substituted at position B30.

Authors:  H P Neubauer; R Obermeier; G Schnorr
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

4.  Aspects of the secondary antibody response to ox insulin in the Hartley guinea-pig; the use of chemically modified ox insulin to delineate the antigenic determinants of ox insulin.

Authors:  P J Hollins; R L Himsworth
Journal:  Clin Exp Immunol       Date:  1976-03       Impact factor: 4.330

5.  Insulin analog with additional disulfide bond has increased stability and preserved activity.

Authors:  Tine N Vinther; Mathias Norrman; Ulla Ribel; Kasper Huus; Morten Schlein; Dorte B Steensgaard; Thomas Å Pedersen; Ingrid Pettersson; Svend Ludvigsen; Thomas Kjeldsen; Knud J Jensen; František Hubálek
Journal:  Protein Sci       Date:  2013-01-17       Impact factor: 6.725

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.